Pediatric Maxillary Giant Cell Tumors: Surgical Management by Transoral and Endoscopic Transnasal Enucleation and Curettage

Dillan F. Villavisanis, Richard J. Schmidt, Joseph A. Napoli

Research output: Contribution to journalArticlepeer-review

Abstract

Giant cell tumors are uncommonly found within the craniofacial skeleton, and of those within the head and neck, are exceedingly rare in the maxilla. Here the authors present 2 cases of large, maxillary giant cell tumors: one presenting with mass-effect symptoms and another presenting from incidental findings on routine orthodontic care. Both patients were treated surgically with transoral and endoscopic transnasal excision and demonstrated favorable surgical results. One patient demonstrated no recurrence after 9 years and the other patient was disease free after 4 years. The authors end by discussing the role of emerging biologic agents, such as denosumab, for treating giant cell tumors of the jaws.

Original languageEnglish
Pages (from-to)E747-E750
JournalJournal of Craniofacial Surgery
Volume33
Issue number7
DOIs
StatePublished - 1 Oct 2022
Externally publishedYes

Keywords

  • biologic agents
  • giant cell tumors
  • maxillary tumors
  • pediatric maxillary tumors

Fingerprint

Dive into the research topics of 'Pediatric Maxillary Giant Cell Tumors: Surgical Management by Transoral and Endoscopic Transnasal Enucleation and Curettage'. Together they form a unique fingerprint.

Cite this